Journal article
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)
Abstract
The pharmacological inhibition of the renin-angiotensin-aldosterone system as a therapeutic strategy is one of the most significant advances in the treatment and prevention of cardiovascular disease in heart failure with reduced ejection fraction and in coronary artery disease. Recently, the addition of neprilysin inhibition to angiotensin receptor blockade has been shown to be even more effective than angiotensin-converting enzyme inhibition …
Authors
Leong DP; McMurray JJV; Joseph PG; Yusuf S
Journal
Journal of the American College of Cardiology, Vol. 74, No. 5, pp. 683–698
Publisher
Elsevier
Publication Date
8 2019
DOI
10.1016/j.jacc.2019.04.068
ISSN
0735-1097